News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Banner con los logos de las empresas participantes en el proyecto LUMINA
Flomics Biotech joins Eurostars project LUMINA to advance lung cancer recurrence detection using liquid biopsy and AI
Healthcare
The project, which launched on June 1, 2025, aims to develop an innovative platform for the non-…
Dos mujeres sonriendo
ORYZON receives European Medicines Agency approval to initiate a Phase Ib study of iadademstat in sickle cell disease
Healthcare · Advanced therapies
First iadademstat clinical trial in non-malignant hematological indications.
Un nuevo hito conseguido: se recluta al primer paciente para el ensayo fase III en cirrosis hepática descompensada.
New milestone for Mikrobiomik: recruits first patient in its LiverGut Phase III trial for decompensated liver cirrhosis
Healthcare · Access to innovation
The biotechnology company Mikrobiomik has begun patient recruitment for LiverGut, the first…
La sede de Oryzon
ORYZON reports financial results and corporate update for half-year ending June 30, 2025
Healthcare
Between December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0…
 ronda en Capital Cell: Mikrobiomik.
Mikrobiomik launches a Capital Cell funding campaign to support its next clinical trial
Healthcare · Access to innovation
Mikrobiomik launches a Capital Cell funding campaign to support its next clinical trial
Científica observando a través de un microscopio
New technology detects breast cancer relapse up to five years before symptoms appear using blood samples
Healthcare · Personalized medicine
A study led by Dr. Iñaki Comino-Méndez and Dr. Emilio Alba from the Hospital Universitario Virgen…
Clesa Innovation Center en Madrid
Kadans presents its new space for innovation in life sciences: Clesa Innovation Center
Healthcare
Located in the heart of biomedical innovation in Madrid, and with an investment of over 35 million…
El equipo gestor de Inveready Innvierte Biotech II ha estado liderado por Sara Secall, Roger Piqué y Josep Maria Echarri.
Inveready successfully closes Inveready Innvierte Biotech II, its second life sciences fund
Financing · Corporate
Inveready completes its third venture capital fund with a 4.3x return on capital invested by…
Gráfica que muestra en un ordenador el crecimiento de una empresa
Expanding analyst interest in ORYZON
Healthcare
New U.S. investment bank joins, bringing total coverage to ten analysts.